My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Biden Set To Ban Future Offshore Oil Drilling...
Winter Storm Blair Blasts Millions Of America...
AMD and Nvidia Overtake Intel in Key Markets,...
Justin Trudeau Will Step Down As Canada Faces...
Big Tech's Date With Antitrust: Alphabet, Met...
Lyft Analyst Says 'Buy Into The Story' Despit...
US Steel, Nippon Steel Sue Biden Administrati...
Alphabet Drives Into 2025: Google's AI, Waymo...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    ACADIA PHARMACEUTICALS INC (NASDAQ: ACAD)

    Overview
    current price
    $17.46
    $17.46
    change
    -0.95 | -5.16%
    -0.95 | -5.16%
    Yesterday's Close
    18.41
    open
    18.41
    volume
    4.54 M
    30d. avg volume.
    3.05 M
    1 day
    17.44 - 18.66
    52 weeks
    14.15 - 31.10
    p/e
    23.60
    beta
    0.3738
    market cap
    3.06 B
    dividend yield
    0.00%
    Industry
    -
    acad by TradingView
    News and Commentary
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    Neuro Drug Stocks Rise Following Intra-CellularTherapies' Drug Approval One indisputable trend about the modern world is that people are living longer. In 1950, the average lifespan for an American was 68 years old. Today, it's 78. One result of a lo...
    Market Summary: Oil Prices Rise After Saudi Arabia Names New Energy Minister Following lack of major U.S. economic data or earnings reports being released early in the week, much of market focus has been toward overseas data and the global economy. The U....
    StockTwits
    StockTwits
    Most Shared
    Warner Bros Discovery Stock Soars After Multi-Year Deal with Comcast; Comcast Shares Slide On Subscriber Loss Estimates
    Rivian's Strong Deliveries, R2 Line Plans And VW JV Expansion Drive Analyst Optimism
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    Most Popular
    Tesla Analysts On Deliveries: EV Stock Could Have 'Stormy Weather' In Short Term, 'Generational Set Of Growth Opportunities' Long Term
    Toyota 2024 US Sales Surge 3.7%, Hits Milestone With Over A Million Electrified Vehicles Sold
    JetBlue Fined $2 Million For 'Chronic Flight Delays': Delta, United Rank Among Most On-Time Airlines
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Covid19
    Tesla
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2025 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?